1 Division of Hematology/Oncology/Bone Marrow Transplant, Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, CA.
2 Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA.
3 Division of Hematology, Children's Health Orange County Children’s Hospital, Orange, CA.
4 Department of Hematology/Oncology, Children’s Hospital Colorado, Aurora, CO.
5 University of Colorado School of Medicine, Aurora, CO.
6 Versiti Blood Research Institute, Milwaukee, WI.
7 Data Coordinating Center, Johns Hopkins All Children’s Institute for Clinical and Translational Research, St. Petersburg, FL.
8 Department of Pediatrics, Yale School of Medicine, New Haven, CT.
9 Department of Hematology, Oncology and Blood and Marrow Transplant, Children’s Mercy Hospital, Kansas City, MO.
10 Division of Hematology/Oncology, Department of Pediatrics, Boston Children’s Hospital, Boston, MA.
11 Harvard Medical School, Boston, MA.
12 Department of Cancer and Blood Disorders, Akron Children’s Hospital, Akron, OH.
13 Department of Hematology/Oncology, Children’s Hospital of Pittsburgh, Pittsburgh, PA.
14 Indiana Hemophilia and Thrombosis Center, Indianapolis, IN.
15 Department of Medicine and Department of Pathology & Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT.
16 Departments of Oncology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.
17 Departments of Pediatrics and Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/pccmjournal).
Dr. Jaffray received grant funding for this study from the National Institutes of Health (NIH) from the National Center for Advancing Translational Science (grant number UL1TR001855), the Children’s Hospital Saban Research Mentored Career Development Award, and The Hemostasis and Thrombosis Research Society Mentored Research Award, supported by an independent educational grant from Takeda Pharmaceuticals U.S.A. Dr. Mahajerin received grant funding from to The Hemostasis and Thrombosis Research Society Mentored Research Award and CHOC Children’s Hospital and University of California Irvine Physician-Scientist Research Award program. Dr. Goldenberg receives salary and research support from NIH National Heart, Lung, and Blood Institute (NHLBI) via a U01 award. Drs. Jaffray, Branchford, and Goldenberg received support for article research from the NIH. Dr. Branchford received funding from Kedrion, Bioproducts Lab, Biomarin, Shire, Innovative Biopharma, Advio, Bayer, and Octapharma. Drs. Branchford and Goldenberg received support for article research from the NHLBI. Dr. Silvey received funding from Genetech and Bayer. Dr. Amankwah received funding from Bristol Myers Squibb and Pfizer. Dr. Goldenberg received funding from the NIH, the NHLBI, Daiici Sankyo, Anthos Therapeutics, and the Academic Research Organization CPC Clinical Research. The remaining authors have disclosed that they do not have any potential conflicts of interest. Funding sources did not have a role in study design, data analysis, writing, or submission of the manuscript. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Akron Children’s Hospital, Boston Children’s Hospital, Children’s Hospital Colorado, Children’s Hospital Los Angeles, Children’s Mercy Kansas City, CHOC Children’s Hospital, Children’s Hospital of Pittsburgh, and Indiana Hemophilia and Thrombosis Center/Peyton Manning Children’s Hospital
For information regarding this article, E-mail: [email protected]
